Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 14.95% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Consumer Staples | 10.7% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Bolt Biotherapeutics
BOLT
$7.67M
| $795K | ﹤0.01% |
14,505
+10,060
| +226% | +$677K |
|
2877
PJT Partners
PJT
$4.3B
| $795K | ﹤0.01% |
12,600
| – | – |
|
2878
Perma-Fix Environmental Services
PESI
$352M
| $794K | ﹤0.01% |
143,567
-12,029
| -8% | -$70.4K |
|
|
FNHC
2879
DELISTED
FedNat Holding Company Common Stock
FNHC
| $794K | ﹤0.01% |
588,461
-8,700
| -1% | -$11.6K |
|
2880
iShares US Utilities ETF
IDU
$1.35B
| $792K | ﹤0.01% |
+8,700
| New | +$740K |
|
2881
AgEagle Aerial Systems
UAVS
$40.9M
| $791K | ﹤0.01% |
664
-794
| -54% | -$938K |
|
|
MTLS
2882
Materialise
MTLS
$368M
| $788K | ﹤0.01% |
40,700
+26,000
| +177% | +$523K |
|
|
MTTR
2883
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $787K | ﹤0.01% |
96,900
+58,400
| +152% | +$553K |
|
2884
Credit Suisse X-Links Silver Shares Covered Call ETNs due April 21 2033
SLVO
$11.3M
| $784K | ﹤0.01% |
7,527
+5,272
| +234% | +$544K |
|
2885
Marcus Corp
MCS
$897M
| $782K | ﹤0.01% |
44,200
+26,000
| +143% | +$456K |
|
|
ATTO
2886
DELISTED
Atento S.A.
ATTO
| $780K | ﹤0.01% |
28,212
-2,011
| -7% | -$52.4K |
|
2887
Aligos Therapeutics
ALGS
$26.2M
| $779K | ﹤0.01% |
14,493
+12,313
| +565% | +$986K |
|
|
OPRA
2888
Opera Ltd
OPRA
$1.69B
| $779K | ﹤0.01% |
131,800
+88,000
| +201% | +$551K |
|
|
TBLT
2889
DELISTED
ToughBuilt Industries, Inc. Common Stock
TBLT
| $779K | ﹤0.01% |
458
+364
| +387% | +$845K |
|
2890
MainStreet Bancshares
MNSB
$164M
| $778K | ﹤0.01% |
31,998
-7,936
| -20% | -$196K |
|
2891
Pulmatrix
PULM
$6.35M
| $776K | ﹤0.01% |
113,620
-8,910
| -7% | -$64.7K |
|
2892
First Trust Water ETF
FIW
$1.85B
| $775K | ﹤0.01% |
9,200
-4,800
| -34% | -$401K |
|
|
MAG
2893
DELISTED
MAG Silver
MAG
| $774K | ﹤0.01% |
47,800
+24,300
| +103% | +$387K |
|
|
EPZM
2894
DELISTED
Epizyme, Inc
EPZM
| $773K | ﹤0.01% |
671,788
+162,600
| +32% | +$265K |
|
2895
Gyre Therapeutics
GYRE
$641M
| $772K | ﹤0.01% |
155,982
-80,272
| -34% | -$398K |
|
|
LTRPA
2896
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $771K | ﹤0.01% |
376,000
+291,400
| +344% | +$617K |
|
|
OTIC
2897
DELISTED
Otonomy, Inc.
OTIC
| $770K | ﹤0.01% |
321,026
-1,800
| -0.6% | -$3.83K |
|
2898
VanEck Morningstar Wide Moat ETF
MOAT
$11.9B
| $769K | ﹤0.01% |
10,300
-1,700
| -14% | -$125K |
|
|
BRSL
2899
Brightstar Lottery PLC
BRSL
$1.84B
| $765K | ﹤0.01% |
31,000
-481,300
| -94% | -$12.9M |
|
2900
Choiceone Financial
COFS
$509M
| $764K | ﹤0.01% |
30,500
+1,261
| +4% | +$32.5K |
|
Similar funds
Renaissance Technologies's Q1 2022 Portfolio in Review
As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
- Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
- Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.